⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethylbenzene SCHEMBL28012872 | 0.80 | ALDH1A1 (0.45) | — | |
| SCHEMBL1456892 | 0.74 | HCAR2 (0.41) | — | |
| SCHEMBL28815828 | 0.70 | RPS6KA3 (0.47) | — | |
| SCHEMBL390310 | 0.70 | — | — | |
| SCHEMBL392004 | 0.70 | — | — | |
| SCHEMBL1994489 | 0.70 | — | — | |
| SCHEMBL18797097 | 0.70 | — | — | |
| SCHEMBL8644938 | 0.70 | — | — | |
| SCHEMBL5671452 | 0.70 | — | — | |
| SCHEMBL725340 | 0.70 | HCAR2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0382634-B1 | Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI ELF (FR) | 1994-05-04 | — | — | EP | claimed |
| JP-6009574-A | — | — | None | — | — | JP | disclosed |
| US-20230340083-A1 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | Vir Biotechnology, Inc. | 2023-10-26 | — | — | US | disclosed |
| CN-116917315-A | Antibodies and methods for treating influenza A infection | 维尔生物科技有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-4259655-A1 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | VIR Biotechnology, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-4114361-A1 | ORAL SOLID PREPARATIONS | Takeda Pharmaceutical Company Limited (JP) | 2023-01-11 | — | — | EP | disclosed |
| US-20220298230-A1 | ANTIBODIES AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | THE ROCKEFELLER UNIVERSITY (US) | 2022-09-22 | — | — | US | disclosed |
| CN-115052630-A | Compositions and methods for treating influenza a infection | 维尔生物科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-20220226470-A1 | ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | Vir Biotechnology, Inc. | 2022-07-21 | — | — | US | disclosed |
| EP-4021502-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION | VIR Biotechnology, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| US-5631255-A | AFFINITY FOR CHOLINERGIC RECEPTORS, TREATMENT OF COGNITIVE AND MEMORY DISORDERS, AND DEGENERATIVE SYNDROMES | SANOFI (FR) | 1997-05-20 | — | — | US | disclosed |
| CN-1141879-A | Process for preparation of phosphorous sulfide | MONSANTO CO (US) | 1997-02-05 | — | — | CN | disclosed |
| EP-0752998-A1 | THIONATION PROCESS USING ELEMENTAL PHOSPHORUS AND SULFUR | MONSANTO COMPANY (US) | 1997-01-15 | — | — | EP | disclosed |
| US-5461053-A | Cognition activator | SANOFI (FR) | 1995-10-24 | — | — | US | disclosed |
| WO-1995026357-A1 | THIONATION PROCESS USING ELEMENTAL PHOSPHORUS AND SULFUR | MONSANTO COMPANY (US) | 1995-10-05 | — | — | WO | disclosed |
| EP-0608215-A1 | QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS | ABBOTT LABORATORIES (US) | 1994-08-03 | — | — | EP | disclosed |
| JP-H069574-A | HERBICIDAL N-CYANOPYRIDAZINONE | AGROLINZ AGRARCHEMIKALIEN GMBH | 1994-01-18 | — | — | JP | disclosed |
| EP-0608215-A4 | QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS. | ABBOTT LAB (US) | 1993-11-11 | — | — | EP | disclosed |
| US-5081119-A | Muscarinic antagonists, dememtia, Alzheimer,s | SANOFI (FR) | 1992-01-14 | — | — | US | disclosed |
| US-4977152-A | For alzheimer*s disease | SOCIETE ANONYME: SANOFI (FR) | 1990-12-11 | — | — | US | disclosed |